Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1639, Issue 3, 2003, Pages 159-168

  Ksiezak Reding, Hanna ^a   Pyo, Han Kyoung ^a   Feinstein, Boris ^a   Pasinetti, Giulio M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Akt protein kinase B; Alzheimer's disease; AT100 epitope; Glycogen synthase kinase 3 ; Protein kinase A; Tau

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; EPITOPE; GLYCOGEN SYNTHASE KINASE 3; ISOPROTEIN; LITHIUM; MONOCLONAL ANTIBODY; PROTEIN KINASE B; SERINE; TAU PROTEIN; THREONINE;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION;

EID: 0242409714     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2003.09.001     Document Type: Article

References (46)

1. Goedert M., Spillantini M.G., Cairns N.J., Crowther R.A. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron. 8:1992;159-168.
2. Goode B.L., Feinstein S.C. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau. J. Cell Biol. 124:1994;769-782.
3. Morita-Fujimura Y., Kurachi M., Tashiro H., Komiya Y., Tashiro T. Reduced microtubule-nucleation activity of tau after dephosphorylation. Biochem. Biophys. Res. Commun. 225:1996;462-468.
4. Biernat J., Mandelkow E.M. The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains. Mol. Biol. Cell. 10:1999;727-740.
5. Stamer K., Vogel R., Thies E., Mandelkow E., Mandelkow E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 156:2002;1051-1063.
6. Lee G., Newman S.T., Gard D.L., Band H., Panchamoorthy G. Tau interacts with src-family non-receptor tyrosine kinases. J. Cell. Sci. 111:1998;3167-3177.
7. Dickson D.W., Liu W.-K., Ksiezak-Reding H., Yen S.H. Corticobasal degeneration: neuropathologic and molecular considerations. Litvan I., Goetz C., Lang A. Corticobasal Degeneration. Adv. Neurol. vol. 82:2000;9-27 Lippincott-Raven Publishers, Philadelphia.
8. Goedert M. Neurofibrillary pathology of Alzheimer's disease and other tauopathies. [Review] Prog. Brain Res. 117:1998;287-306.
9. Matsuo E.S., Shin R.-W., Billingsley M.L., Van deVoorde A., O'Connor M., Trojanowski J.Q., Lee V.M.-Y. Biopsy-derived adult human brain tau is phosphorylated at many of the same sites as Alzheimer's disease paired helical filament tau. Neuron. 13:1994;989-1002.
10. Zheng-Fischhofer Q., Biernat J., Mandelkow E.M., Illenberger S., Godemann R., Mandelkow E. Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical- filament-like conformation. Eur. J. Biochem. 252:1998;542-552.
11. Drewes G., Ebneth A., Mandelkow E.M. MAPs, MARKs and microtubule dynamics. Trends Biochem. Sci. 23:1998;307-311. (Review).
12. Illenberger S., Zheng-Fischhofer Q., Preuss U., Stamer K., Baumann K., Trinczek B., Biernat J., Godemann R., Mandelkow E.M., Mandelkow E. The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. Mol. Biol. Cell. 9:1998;1495-1512.
13. Schneider A., Biernat J., von Bergen M., Mandelkow E., Mandelkow E.M. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry. 38:1999;3549-3558.
14. Alessi D.R., Caudwell F.B., Andjelkovic M., Hemmings B.A., Cohen P. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399:1996;333-338.
15. Andjelkovic M., Jakubowicz T., Cron P., Ming X.F., Han J.W., Hemmings B.A. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/Akt) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 93:1996;5699-5704.
16. Coffer P.J., Jin J., Woodgett J.R. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. [Review] Biochem. J. 335:1998;1-13.
17. Franke T.F., Yang S.I., Chan T.O., Datta K., Kazlauskas A., Morrison D.K., Kaplan D.R., Tsichlis P.N. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 81:1995;727-736.
18. Hemmings B.A. Akt signaling: linking membrane events to life and death decisions. Science. 275:1997;628-630.
19. Fukunaga K., Kawano T. Akt is a molecular target for signal transduction therapy in brain ischemic insult. [Review] J. Pharmacol. Sci. 92:2003;317-327.
20. Dajani R., Fraser E., Roe S.M., Young N., Good V., Dale T.C., Pearl L.H. Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell. 105:2001;721-732.
21. Kennedy S.G., Kandel E.S., Cross T.K., Hay N. Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell. Biol. 19:1999;5800-5810.
22. Gottlob K., Majewski N., Kennedy S., Kandel E., Robey R.B., Hay N. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 15:2001;1406-1418.
23. Crowther R.A., Olesen O.F., Smith M.J., Jakes R., Goedert M. Assembly of Alzheimer-like filaments from full-length tau protein. FEBS Lett. 337:1994;135-138.
24. Ksiezak-Reding H., Yang G., Simon M., Wall J.S. Assembled tau filaments differ from native paired helical filaments as determined by scanning transmission electron microscopy (STEM). Brain Res. 814:1998;86-98.
25. Gordon-Krajcer W., Yang L.S., Ksiezak-Reding H. Conformation of paired helical filaments blocks dephosphorylation of epitopes shared with fetal tau except Ser199/202 and Ser202/Thr205. Brain Res. 856:2000;163-175.
26. Fabbro D., Batt D., Rose P., Schacher B., Roberts T.M., Ferrari S. Homogeneous purification of human recombinant GST-Akt/PKB from Sf9 cells. Protein Expr. Purif. 17:1999;83-88.
27. Kumar C.C., Diao R., Yin Z., Liu Y., Samatar A.A., Madison V., Xiao L. Expression, purification, characterization and homology modeling of active Akt/PKB, a key enzyme involved in cell survival signaling. Biochim. Biophys. Acta. 1526:2001;257-268.
28. Gadbois D.M., Crissman H.A., Tobey R.A., Bradbury E.M. Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. Proc. Natl. Acad. Sci. U. S. A. 89:1992;8626-8630.
29. Stambolic V., Ruel L., Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr. Biol. 6:1996;1664-1668.
30. Ksiezak-Reding H., He D., Gordon-Krajcer W., Kress Y., Lee S., Dickson D.W. Induction of Alzheimer-specific tau epitope AT100 in apoptotic human fetal astrocytes. Cell Motil. Cytoskel. 47:2000;236-252.
31. Kenessey A., Yen S.H. The extent of phosphorylation of fetal tau is comparable to that of PHF-tau from Alzheimer paired helical filaments. Brain Res. 629:1993;40-46.
32. Scott C.W., Spreen R.C., Herman J.L., Chow F.P., Davison M.D., Young J., Caputo C.B. Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly. J. Biol. Chem. 268:1993;1166-1173.
33. Jicha G.A., Weaver C., Lane E., Vianna C., Kress Y., Rockwood J., Davies P. cAMP-dependent protein kinase phosphorylation on tau in Alzheimer's disease. J. Neurosci. 19:1999;7486-7494.
34. Hanger D.P., Hughes K., Woodgett J.R., Brion J.P., Anderton B.H. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147:1992;58-62.
35. Song J.S., Yang S.D. Tau protein kinase I/GSK-3 beta/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser369, and Ser400 sites phosphorylated in Alzheimer disease brain. J. Protein Chem. 14:1995;95-105.
36. Leger J., Kempf M., Lee G., Brandt R. Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau. J. Biol. Chem. 272:1997;8441-8446.
37. Wang Q., Liu L., Pei L., Ju W., Ahmadian G., Lu J., Wang Y., Liu F., Wang Y.T. Control of synaptic strength, a novel function of Akt. Neuron. 38:2003;915-928.
38. Lesort M., Blanchard C., Yardin C., Esclaire F., Hugon J. Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivation. Brain Res. Mol. Brain Res. 45:1997;127-132.
39. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J.H., Petersen R.C., Parisi J.E., Hyman B.T. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41:1997;17-24.
40. Morsch R., Simon W., Coleman P.D. Neurons may live for decades with neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 58:1999;188-197.
41. Fath T., Eidenmuller J., Brandt R. Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease. J. Neurosci. 22:2002;9733-9741.
42. Pei J.J., Khatoon S., An W.L., Norlinder M., Tanaka T., Braak H., Tsujio I., Takeda M., Alafuzoff I., Winblad B., Cowburn R.F., Grundke-Iqbal I., Iqbal K. Role of protein kinase B in Alzheimer's neurofibrillary pathology. Acta Neuropathol. 105:2003;381-392.
43. Stein T.D., Johnson J.A. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J. Neurosci. 22:2002;7380-7388.
44. Sun W., Qureshi H.Y., Cafferty P.W., Sobue K., Agarwal-Mawal A., Neufield K.D., Paudel H.K. Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules. J. Biol. Chem. 277:2002;11933-11940.
45. Planel E., Yasutake K., Fujita S.C., Ishiguro K. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J. Biol. Chem. 276:2001;34298-34306.
46. Okawa Y., Ishiguro K., Fujita S.C. Stress-induced hyperphosphorylation of tau in the mouse brain. FEBS Lett. 535:2003;183-189.